Researchers developed MAGIC, an AI-based system integrating automated microscopy and genomics to study chromosomal abnormalities linked to cancer.
Key Details
- 1MAGIC uses automated microscopy, AI-driven image analysis, and single-cell genome sequencing to identify and tag abnormal cells.
- 2The system can analyse nearly 100,000 cells in less than a day, vastly exceeding manual methods.
- 3Chromosomal abnormalities were seen in just over 10% of cell divisions, doubling with mutated p53 gene.
- 4MAGIC relies on a laser and photoconvertible dye to mark target cells, facilitating further analysis.
- 5The tool is versatile and can be trained to identify a variety of visually distinct cellular features.
Why It Matters
MAGIC represents a significant step forward in combining imaging AI and genomic methods for the high-throughput study of cellular abnormalities, offering potential advances in cancer detection and understanding cancer origins. Such AI-driven image analysis tools could pave the way for faster, more precise research and diagnostics in radiology and oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.